NCI National Clinical Trials Network (NCTN) Program Guidelines

More documents

Recommendations

Info

PART 1: Overview of NCTN Program Section IV – Terms/Conditions of Award – Appeals Process Center, the Director will direct NCI/DCTD to consider the proposal under the appropriate evaluation or review procedures for the NCTN Program as described in Part 1 – Section IV.C.3.1. of these Guidelines. Page 92 of 241
PART 1: Overview of NCTN Program Section V – Other Administrative Considerations V. Other NCI Administrative Considerations A. Program Staff Administration of the NCTN Program Within NCI/DCTD, major scientific policy and programmatic decisions concerning the NCI National Clinical Trials Network (NCTN) Program are made only after appropriate consultation with and involvement by the responsible Lead NCTN Program Director, the Co-Program Directors of the NCTN Program, the Project Scientists, NCI/DCTD Branch Chiefs and Program Chiefs that are involved in the Program, and the Associate Director, CTEP, DCTD, as necessary and appropriate. Routine programmatic administration is the responsibility of the responsible Lead NCTN Program Director, who assures uniformity of implementation across the various key components in conjunction with the Co-Program Directors of the NCTN Program and the Project Scientists. The Lead NCTN Program Director or his/her designee has responsibility for addressing and approving noncompetitive award (Type 5) budget requests, any supplemental budget requests, and new/competitive award (Type 1) budgets, as well as future Type 2 applications. The responsible Lead NCTN Program Director will administer these tasks in conjunction with the Grants Management Specialist in the Office of Grants Administration (OGA) and will be assisted by the Co-Program Directors of the NCTN Program and the Project Scientists for the key components of the NCTN Program as well as the NCI/DCTD Senior Program Specialist for the Program. B. Senior Program Specialist for the NCTN Program The NCI/DCTD Senior Program Specialist for the NCTN Program works closely with the responsible Lead NCTN Program Director in reviewing administrative materials supporting Group requests, performing budget analyses, and facilitating the completion of action items involving coordination between NCI/DCTD, the NCI Office of Grants Administration (OGA), and the awardees under the Program. The NCI/DCTD Senior Program Specialist exchanges information with the Network Group Directors of Operations for the key components of the NCTN Program and OGA staff on administrative changes and priorities. C. NCI Office of Grants Administration (OGA) The Grants Management Specialist for the NCI Office of Grants Administration (OGA) is responsible for the fiscal and administrative aspects of each application and award. The Grants Management Specialist for OGA works closely with the responsible Lead NCTN Program Director and NCI/DCTD Senior Program Specialist to assure that appropriate science is funded in accordance with applicable laws, regulations, policies, and peer review recommendations to the extent that the budget allows and NCI priorities dictate. D. Miscellaneous Budgetary Considerations 1. Carryover Requests Carry-over requests will be entertained in situations where circumstances prevented funding from being spent during the budget period for which it was provided and where funding is not replicated in the current budget year for an ongoing expense. 2. Requests for Non-competing Supplemental Funding Informal discussions about the possibility of receiving non-competing supplemental funding for special needs and/or additional funding to cover data collection and management and biospecimen collection on a per case basis may be initiated by the awardee for the key component of the NCTN Program. However, formal requests must be made for funding to be received and must always be countersigned by the business official responsible for the Cooperative Agreement/grant and the Principal Investigator(s). Electronic facsimile signatures on documents transmitted via email are acceptable. Most requests, however, will require the use of a Form PHS 398/SF424 or PHS 2590 to capture the details of the requested budget. The original should be sent to the responsible Lead NCTN Program Director, in care of the NCI/DCTD Senior Program Specialist. Page 93 of 241
Page 1 and 2:
NATIONAL CANCER INSTITUTE NATIONAL
Page 3 and 4:
NCTN Program Guidelines Table of Co
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
PART 1: Overview of NCTN Program Se
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
PART 1: Overview of the NCTN Progra
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42: PART 1: Overview of NCTN Program Se
Page 91: PART 1: Overview of NCTN Program Se
Page 95 and 96: PART 2: Submission of Competing New
Page 101 and 102: PART 2: Submission of New/Competing
Page 143 and 144:
PART 2: Submission of New/Competing
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
PART 3: Submission of Non-Competing
Page 189 and 190:
TYPE OF STUDY PART 3: Submission No
Page 191 and 192:
PART 3: Submission Non-Competing Ap
Page 193 and 194:
PART 3: Submission Non-Competing Ap
Page 195 and 196:
PART 4: Appendices Section II - Req
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Participating Site Member Category
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
PART 4: Appendices Section IV - Cos
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
PART 4: Appendices Section V - Impo
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Part 4: Appendices - VI. Sample Tab
Page 225 and 226:
Part 4: Appendices - VII. Model for
Page 227 and 228:
Part 4: Appendices - VII. NCTN Prog
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Part 4: Appendices - IX. Common Bud
Page 235 and 236:
Part 4: Appendices - IX. Common Bud
Page 237 and 238:
Part 4: Appendices - VII. Accrual I
Page 239 and 240:
Part 4: Summary of Updates to Guide
Page 241:
Part 4: Summary of Updates to Guide
show all

NCI National Clinical Trials Network (NCTN) Program Guidelines

Create successful ePaper yourself

Delete template?

Save as template?